Skip to content Skip to contact
Global Vox Populi

Proprietary research panels.

Twelve first-party, consented and validated panels — consumer, professional and clinical — built for precise, low-incidence targeting across 190+ markets. Open any panel to model feasibility for your study, live.

Our proprietary panels are recruited and owned by Global Vox Populi — not rented from the open market. Members opt in, are validated against profession and (for clinical panels) registration and licence, and are profiled on 45–140 data points so we can field tightly defined, hard-to-reach audiences with confidence.

Each panel below is a working feasibility tool. Set your incidence, response rate and target completes, and the coverage tables update market-by-market with a feasible-completes figure and a Robust / Moderate / Limited flag — the same scoping we use when we quote a study.

B2B

B2B & IT Decision-Makers

Verified business professionals and IT decision-makers, profiled by function, seniority, industry and technology remit.

4,912,638
Panelists
193
Markets
Open feasibility explorer →
B2C

B2C Consumers

A deep general-population consumer panel with specialist layers — retail investors, gamers, people with disabilities and multicultural segments.

29,093,467
Panelists
193
Markets
Open feasibility explorer →
Healthcare-adjacent

Caregivers

Unpaid and paid caregivers profiled by care relationship, condition area, care intensity and demographics.

1,918,200
Panelists
173
Markets
Open feasibility explorer →
B2C

Children & Parents

Parent-proxy and consented-teen access across child age bands, gender, location and consent mode.

2,388,833
Panelists
193
Markets
Open feasibility explorer →
B2B

Financial Professionals

Advisers, bankers and asset managers by profession, institution type, assets under management and seniority.

542,104
Panelists
193
Markets
Open feasibility explorer →
B2B

Foodservice & HoReCa Chefs

Chefs and foodservice operators by outlet type, role, establishment size and purchase authority.

482,665
Panelists
193
Markets
Open feasibility explorer →
Healthcare

Healthcare Professionals

Physicians and HCPs across 70+ specialties and sub-specialties, validated against registration and licence.

2,738,904
Panelists
194
Markets
Open feasibility explorer →
Healthcare

Key Opinion Leaders

Recognised clinical key opinion leaders across specialties, validated and referral-nominated.

192,167
Panelists
195
Markets
Open feasibility explorer →
Healthcare

Nurses & Allied Health

Registered nurses, advanced-practice nurses and allied-health professionals across care settings.

6,520,850
Panelists
184
Markets
Open feasibility explorer →
Healthcare

Patients

Diagnosed patients across therapeutic areas and specific conditions, with feasible reach by market.

71,411,997
Patient reach
193
Markets
Open feasibility explorer →
Healthcare

Payers & Providers

Payer and provider decision-makers across access, coverage, clinical policy and administration.

77,080
Panelists
194
Markets
Open feasibility explorer →
B2B

Tradespeople & Contractors

Skilled trades and contractors by trade, business structure, work type, experience and purchase role.

447,196
Panelists
193
Markets
Open feasibility explorer →

Governance

Built to the standards buyers audit for.

Every proprietary panel is recruited, validated and fielded under the same documented operating standard — ICC/ESOMAR, Insights Association and BHBIA aligned, and ISO-certified.

Standards & ethical guidelines
  • Operates to the ICC/ESOMAR International Code, the Insights Association Code of Standards & Ethics, and the BHBIA Legal & Ethical Guidelines.
  • Follows applicable pharmacovigilance / adverse-event reporting obligations.
  • Certified to ISO 9001:2026 (Quality Management), ISO 20252:2026 (Market, Opinion & Social Research) and ISO/IEC 27001:2022 (Information Security).
Recruitment & validation
  • By invitation and referral-led: professional-association partnerships, verified medical/nursing registries, accredited CME and clinical communities, congress/event sign-ups and targeted verified outreach.
  • No incentivised open-web sign-up for clinical roles.
  • Each clinical member validated against profession, registration/licence status and specialty at recruitment.
  • Re-validated on a rolling basis via registry/licence checks (e.g. NMC, NPI, state/board and national registers), employer/association verification and document checks where required.
Consent & data protection
  • 100% opt-in with double opt-in confirmation.
  • Granular, revocable consent for research contact, data processing and — where relevant — health-data handling.
  • Right-to-withdraw and data-subject requests honoured on demand.
  • Compliant with GDPR (EU/UK), India DPDP Act 2023, CCPA/CPRA and local equivalents.
  • Data minimisation, purpose limitation, and encryption in transit and at rest.
  • Country data-residency options; PII segregated from response data.
Fraud & quality controls
  • De-duplication (device + identity fingerprinting); digital-fingerprint and geo/VPN checks.
  • Trap/attention questions; straight-lining and speeding detection; completion-quality scoring.
  • Bots and fraudulent completes removed pre-delivery; consistently low-quality members retired.
Profiling
  • 45–140 data points per member, depending on market maturity.
  • Covers profession, specialty/sub-specialty, seniority/grade, care setting, institution type, years in practice, patient volumes, therapy areas, prescribing/decision role, procedures, technology use, languages and more.
  • Enables precise low-incidence targeting.
Feasibility
  • Shown per market with a Robust / Moderate / Limited flag.
  • Includes an estimated feasible-completes figure for a broad study in a single field window.
  • Low-incidence and sub-specialty studies scoped case-by-case; recruit-to-order tops up thin cells in the smallest markets.
Methodology
  • CAWI online (desktop/mobile-first).
  • CATI and mobile/WhatsApp-assisted collection where clinician preference or connectivity requires it.
  • Multi-language survey delivery with localised translation and QA.
Adverse-event (AE) reporting — healthcare
  • All fieldwork touching a marketed product carries pharmacovigilance obligations; interviewers and scripts are AE-trained.
  • Any suspected adverse event or product complaint is captured and reported to the client/MAH — typically within 24 hours — per BHBIA guidance.
  • AE-handling SOP, reconciliation logs and annual AE training are maintained.
Recruitment sources & incentives
  • Physician referrals and peer nomination; verified professional opt-in via GVP registration; medical associations and societies; conference/in-person recruitment; vetted physician-network partners where GVP fields through alliances.
  • No incentivised list-buying — members are recruited to research-only panels; purchased contact lists are never appended as consented members.
  • Fair incentives: honoraria set at fair-market value by specialty and market, per ESOMAR/BHBIA guidance.
Compliance summary
  • ESOMAR — ICC/ESOMAR International Code; the ESOMAR "37 Questions to Help Buyers of Online Samples" is completed and available on request.
  • Insights Association — IA Code of Standards and Ethics.
  • BHBIA — Legal & Ethical Guidelines, including adverse-event (pharmacovigilance) reporting and annual AE training for research staff.
  • ISO 20252 & ISO 27001 — processes and information-security controls aligned to the standards.
  • Regulatory — EU/UK GDPR, DPA 2018, DPDP Act 2023 and applicable local data-protection laws; lawful basis, data-subject rights and retention limits enforced.
  • Security & residency — encryption in transit and at rest, role-based access, audit logging and regional data-residency options where required.

Let's begin

Ready to hear what your market actually thinks?

Tell us the decision you're trying to make. We'll come back with what we'd field — usually within four business hours.

Brief us on a study